IDHIPLI

Swiss trademark · 694226 · Word mark · In force

Register entry

Registration number
694226
Application number
59747/2016
Status
In force
Type
Word mark
Filed
Aug 17, 2016
Registered
Oct 20, 2016
Published
Oct 20, 2016
Protected until
Aug 17, 2026
Source
Swissreg

Goods and services

Pharmaceuticals

Préparations pharmaceutiques pour usage dans le traitement de syndromes beta-thalassémique et myélodysplasique, de maladies auto-inflammatoires, de maladies auto-immunes, de maladies du sang, de cancers, d'arthrites, de maladies musculo-squelettiques et de maladies de la peau, dans les domaines de l'oncologie, de l'immunologie et de l'inflammation; préparations pharmaceutiques, notamment médicaments inhibiteurs de cytokines; préparations pharmaceutiques destinées à moduler le système immunitaire.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 22, 2021

    Agent removed

    Representative
    Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex (removed)

    Published in Swissreg on 22.06.2021

  2. Jun 22, 2021

    Agent entered

    Representative
    Troller Hitz Troller, Rechtsanwälte, Schweizerhofquai 2, Postfach, 6002 Luzern

    Published in Swissreg on 22.06.2021

  3. Oct 20, 2016

    Registered

    Published in Swissreg on 20.10.2016

Parties

Holder

Celgene Corporation

86 Morris Avenue, Summit (NJ 07901), US

Agent

Troller Hitz Troller, Rechtsanwälte

Schweizerhofquai 2 Postfach, 6002 Luzern

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.